U.S., June 23 -- ClinicalTrials.gov registry received information related to the study (NCT07661771) titled 'Individualized Primary Clinical Target Volume Based on Margin Expansion for Nasopharyngeal Carcinoma' on June 10.
Brief Summary: This is a non-inferiority, multicenter, randomized phase 3 trial aimed at investigating the impact of individualized primary clinical target volume based on margin expansion on patients' prognosis and complications compared with the consensus primary clinical target volume based on margin expansion and stepwise extension pattern for patients with newly diagnosed non-metastatic nasopharyngeal carcinoma.
Study Start Date: July 01
Study Type: INTERVENTIONAL
Condition:
Non-metastatic Nasopharyngeal Carcino...